Barricade Therapeutics Corp

Barricade Therapeutics Corp. is a privately held biotechnology company with offices in both Houston and Dallas, Texas. Employing a team of 5 to 9 individuals, Barricade Therapeutics focuses on the research and development of innovative therapies within the field of cancer biology. The company specializes in the discovery and advancement of novel small molecule drugs. Their approach integrates expertise in complex molecule synthesis, chemistry, and molecular pharmacology to develop targeted therapeutic solutions for cancer treatment. While specific product offerings are not publicly listed, their research and development efforts suggest a focus on providing groundbreaking treatments for this complex disease. Barricade Therapeutics differentiates itself through its unique blend of scientific disciplines. By combining expertise in chemistry, pharmacology, and cancer biology, they aim to develop first-in-class therapies that address unmet medical needs in oncology. For more information about Barricade Therapeutics Corp. and their groundbreaking research, visit their website at barricadetherapeutics.com.